Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Targeted molecular therapeutic options for hepatocellular carcinoma
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeted molecular therapeutic options for hepatocellular carcinoma'. Together they form a unique fingerprint.
Liver Neoplasms
Medicine & Life Sciences
100%
Hepatocellular Carcinoma
Medicine & Life Sciences
80%
Molecular Targeted Therapy
Medicine & Life Sciences
68%
lenvatinib
Medicine & Life Sciences
41%
Growth Inhibitors
Medicine & Life Sciences
32%
Sorafenib
Medicine & Life Sciences
30%
Drug Therapy
Medicine & Life Sciences
29%
Hepatitis
Medicine & Life Sciences
23%
Cite this